Molecular pathophysiology of Parkinson's disease

被引:963
|
作者
Moore, DJ [1 ]
West, AB
Dawson, VL
Dawson, TM
机构
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA
关键词
alpha-synuclein; parkin; mitochondrial complex-I; ubiquitin-proteasome system; oxidative stress;
D O I
10.1146/annurev.neuro.28.061604.135718
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra. Although the etiology of PD is incompletely understood, the recent discovery of genes associated with rare monogenic forms of the disease, together with earlier studies and new experimental animal models, has provided important and novel insight into the molecular pathways involved in disease pathogenesis. Increasing evidence indicates that deficits in mitochondrial function, oxidative and nitrosative stress, the accumulation of aberrant or misfolded proteins, and ubiquitin-proteasome system dysfunction may represent the principal molecular pathways or events that commonly underlie the pathogenesis of sporadic and familial forms of PD.
引用
收藏
页码:57 / 87
页数:31
相关论文
共 50 条
  • [41] Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease
    Doria, Margaux
    Maugest, Lucie
    Moreau, Thibault
    Lizard, Gerard
    Vejux, Anne
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 101 : 393 - 400
  • [42] An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson's Disease
    Schechter, Meir
    Sharon, Ronit
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (04) : 1725 - 1750
  • [43] Basal Ganglia Pathophysiology in Parkinson's Disease Reply
    Obeso, Jose A.
    Olanow, C. Warren
    ANNALS OF NEUROLOGY, 2009, 65 (05) : 618 - 619
  • [44] A new approach to understand the pathophysiology of Parkinson's disease
    Nambu, A
    JOURNAL OF NEUROLOGY, 2005, 252 (Suppl 4) : 1 - 4
  • [45] Synchronized neural oscillations and the pathophysiology of Parkinson's disease
    Oswal, Ashwini
    Brown, Peter
    Litvak, Vladimir
    CURRENT OPINION IN NEUROLOGY, 2013, 26 (06) : 662 - 670
  • [46] Neuropathology and pathophysiology of Parkinson's disease: Focus on α-synuclein
    Prigent, Alice
    Lionnet, Arthur
    Corbille, Anne-Gaelle
    Derkinderen, Pascal
    PRESSE MEDICALE, 2017, 46 (02): : 182 - 186
  • [47] Dysphagia in Parkinson's Disease: Pathophysiology, Diagnosis and Therapy
    Suttrup, I.
    Warnecke, T.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2016, 84 : S18 - S23
  • [48] The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease
    Blandini, F
    FUNCTIONAL NEUROLOGY, 2001, 16 (04) : 99 - 106
  • [49] Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease
    Ozkizilcik, Asya
    Sharma, Aruna
    Vicente Lafuente, Jose
    Muresanu, Dafin F.
    Castellani, Rudy J.
    Nozari, Ala
    Tian, Z. Ryan
    Moessler, Herbert
    Sharma, Hari Shanker
    NANONEUROPROTECTION AND NANONEUROTOXICOLOGY, 2019, 245 : 201 - 246
  • [50] Pathophysiology of Parkinson's disease. Will Amyloid loading PET help predict dementia in Parkinson's disease?
    Lorenzo-Bosquet, Carles
    Miquel-Rodriguez, Francesc
    REVISTA DE NEUROLOGIA, 2010, 50 : S24 - S25